Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
It belongs to the GLP-1 receptor agonist class of drugs and works by mimicking a natural hormone involved in appetite regulation and glucose metabolism
Together, those countries account for 69 percent of the worlds type 2 diabetics and 84 percent of people with clinical obesity
According to UVA Health, loss of muscle mass can have a negative impact on patients long-term metabolic health, frailty and overall longevity
Eli Lilly and Novo Nordisk have sued several compounding pharmacies for making copies of their drugs, with mixed results
Eligibility depends on BMI criteria and clinical suitability
Single Vial, Five Pack Share your love Related products Quick view icon ADAMAX Starting at $60.00 SOLD OUTQuick view icon GLP-Tirz (Oral) Starting at $40.00 Quick view icon GLOW (GHK + TB + BPC) Starting at $85.00 Quick view icon GLP-Reta Starting at $115.00
